Trial Profile
Endothelin Receptor Blockade [BQ 123] in Acute ST-elevation Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs PMZ-2123 (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 03 Apr 2014 Results published in the Thrombosis and Haemostasis.
- 05 Apr 2011 Results presented at the 60th Annual Scientific Session of the American College of Cardiology.
- 17 Dec 2009 Planned end date changed from 1 Aug 2009 to 1 Aug 2012 as reported by ClinicalTrials.gov.